By Peter A. McCullough, MD, MPH
The public is on alert for myocarditis, blood clots, and neurologic damage with COVID-19 vaccination, but fewer in the country are talking about new skin rashes. A paper from Seirafianpour et al summarized a stunning 180 papers/reports from the first seven months of the vaccination campaign alone, describing in exhaustive tables the wide range of skin rashes and disorders of the mucosal surfaces (mouth/nose/anus) where the Spike protein from the vaccine and or inflammatory mediators cause dermatological manifestations. There has never been a vaccine that has this degree of well-documented, serious dermatological toxicity.
One of the main findings from the authors is described here: “The side effects were most frequently reported within the first 3 days after vaccination, but there were also some studies reporting delayed adverse reactions, up to 4 weeks after vaccination. Duration of reactions varied from most frequently almost 1 day to as long as 4 weeks or more. The most common location of mucocutaneous lesions was upper limbs (injection site), trunk and face. Almost half of these studies reported participants’ comorbidities. The most commonly reported comorbidities were hypertension, prior COVID-19, diabetes mellitus, cardiovascular disorders, autoimmune, rheumatologic or allergic disorders, malignancies, obesity, and anaphylaxis.”
This paper makes it clear that if one has an auto-immune or allergic disorder at baseline, than a COVID-19 vaccine is asking for big trouble. Other conditions listed should serve as similar caveats. Many of these rashes are long-lasting, will require dermatology appointments, and in some cases need intermittent and expensive intravenous infusions. The vaccines have been recommended to be removed from the market and at this time cannot be advised for anyone.